Michelle R. Caunca

Before lowering blood pressure to prevent ARIA, we need evidence of net benefit

Amyloid-related imaging abnormalities (ARIA) occur in 20-40% of patients treated with the amyloid-targeting drugs lecanemab and donanemab. While most cases of ARIA are asymptomatic, serious and fatal cases occur. Therefore, ARIA prevention remains vital as these drugs are increas...

Before lowering blood pressure to prevent ARIA, we need evidence of net benefit

Amyloid-related imaging abnormalities (ARIA) occur in 20-40% of patients treated with the amyloid-targeting drugs lecanemab and donanemab. While most cases of ARIA are asymptomatic, serious and fatal cases occur. Therefore, ARIA prevention remains vital as these drugs are increas...